Funded Tech Companies
REN Pharmaceuticals
Wondering who invested in REN Pharmaceuticals? Sanderling Ventures, Amgen Ventures and Venrock joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
REN Pharmaceuticals
Company Status
Out of Business
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
270 E. Grand Ave.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
The company's mission is to develop and commercialize breakthrough therapeutics for renal diseases and associated cardio-renal diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/30/2008
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Narachi
VP - Bus. Development
Angie You
Company Investors
- Sanderling Ventures (Paul Grayson)
- Amgen Ventures (Michael Narachi)
- Venrock (Bryan Roberts)
Browse more funded tech companies:
Ren Labs | ReNAgade Therapeutics
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs